Related Experiment Video
Updated: Oct 17, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene
K Wulff1, K Bykowska, S Lopaciuk
1Institute of Human Genetics, Ernst-Moritz-Arndt University, Greifswald, Germany.
Insights
This study investigated the genetic causes of hemophilia B in Polish patients, finding significant genetic diversity. Researchers identified numerous mutations in the factor IX gene, highlighting the heterogeneity of this bleeding disorder.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Hemophilia B is a genetic bleeding disorder caused by deficiency of coagulation factor IX.
- Understanding the molecular basis of factor IX deficiency is crucial for diagnosis and potential therapeutic strategies.
Purpose of the Study:
- To investigate the molecular basis of factor IX deficiency in 53 unrelated Polish patients.
- To identify specific gene defects within the factor IX gene responsible for hemophilia B in this cohort.
Main Methods:
- Utilized heteroduplex analysis and direct sequencing of polymerase chain reaction (PCR) products.
- Analyzed the factor IX gene in 53 unrelated Polish patients diagnosed with hemophilia B.
Main Results:
- Identified 43 distinct point mutations in the factor IX gene among 47 affected patients.
- Detected 29 missense, 9 nonsense, 4 splice site mutations, and 1 promoter region mutation.
- Discovered 12 novel mutations, underscoring genetic variability.
Conclusions:
- The study emphasizes a very high degree of genetic heterogeneity in hemophilia B within the Polish population.
- The findings contribute to the comprehensive understanding of factor IX gene mutations and their role in hemophilia B.
Abstract:
We examined the molecular basis of factor IX deficiency in 53 unrelated Polish patients with hemophilia B. Heteroduplex analysis and direct sequencing of polymerase chain reaction (PCR) products were applied to identify the gene defect. Forty-three different point mutations were detected in the factor IX gene of 47 patients. There were 29 missense mutations, 9 nonsense mutations, 4 splice site mutations and 1 point mutation in the promoter region. Twelve mutations were novel. The results of this study emphasize a very high degree of heterogeneity of hemophilia B.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Pedigree Analysis

